{"id":"bnt162b1","safety":{"commonSideEffects":[{"rate":"90.7%","effect":"Pain at injection site"},{"rate":"83.2%","effect":"Fatigue"},{"rate":"82.1%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL4650454","moleculeType":"Oligonucleotide"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BNT162b1 is a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine encoding the SARS-CoV-2 spike protein.","oneSentence":"mRNA-based vaccine","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:20:02.344Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 prevention"}]},"trialDetails":[{"nctId":"NCT04368728","phase":"PHASE2, PHASE3","title":"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2020-04-29","conditions":"SARS-CoV-2 Infection, COVID-19","enrollment":46969},{"nctId":"NCT06925906","phase":"","title":"Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2023-07-05","conditions":"Abdominal Cancer","enrollment":30},{"nctId":"NCT04380701","phase":"PHASE1, PHASE2","title":"A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2020-04-23","conditions":"Infections, Respiratory, Virus Diseases, Infection Viral","enrollment":512},{"nctId":"NCT04523571","phase":"PHASE1","title":"Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2020-07-28","conditions":"SARS-CoV-2","enrollment":144}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"OVERDOSE"},{"count":1,"reaction":"ACUTE RESPIRATORY FAILURE"},{"count":1,"reaction":"CARDIAC ARREST"},{"count":1,"reaction":"HYPOKALAEMIA"},{"count":1,"reaction":"SUICIDE ATTEMPT"},{"count":1,"reaction":"SYNCOPE"}],"_approvalHistory":[],"publicationCount":22,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BNT162b1","genericName":"BNT162b1","companyName":"BioNTech SE","companyId":"biontech-se","modality":"Biologic","firstApprovalDate":"","aiSummary":"mRNA-based vaccine Used for COVID-19 prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":3},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}